Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene and Rimostil for Perimenopause-Related Depression
NCT00030147Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Feb 2002
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raloxifene, Red clover extract in perimenopausal depression, sponsored by National Institute of Mental Health. Started Feb 2002; status: completed.
02
Drugs
raloxifeneRed clover extract
03
Conditions
perimenopausal depression
Beyond the preview
Go deeper on NCT00030147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030147.